Monday 15 February 2021 2:00pm to Sunday 31 October 2021 2:00pm
About
Deadline for applications: Friday 15 January
Apply: Here
As part of their Entrepreneurial Programmes Initiative, Bruntwood SciTech have announced the launch of the Alderley Park Oncology Development Programme. This national programme, co-funded by Innovate UK and supported by a collaboration of global big pharma and research institutions, will find and develop start-up projects with the potential to improve the diagnosis and treatment of cancer. This 3-day pre-accelerator boot camp will cover the basics of entrepreneurship, before 6-8 companies are chosen to progress to the 6-month intensive accelerator stage. Expertise and mentorship will be provided by a unique partnership of AstraZeneca, Johnson & Johnson Innovation, GlaxoSmithKline, Roche, The Christie NHS Foundation Trust, the Manchester Cancer Research Centre and Medicines Discovery Catapult, who will act as delivery partner for the programme. They will work closely with the researchers to help them develop fully validated, timed and costed project plans to improve their chances of attracting future investment.
Researchers will not only gain exposure from big pharma, but also the opportunity to receive up to £60k funding investment and lab/office space at Alderley Park – the UK’s largest single science campus. Learn more on the Cancer Research UK website. The programme is run from Febrauary- October 2021 and the deadline for applications is Friday 15th January 2021. Register your interest here.